Argenx
ARGX
#478
Rank
S$65.54 B
Marketcap
S$1,059
Share price
1.20%
Change (1 day)
26.65%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): S$11.52

According to Argenx 's latest financial reports the company's current EPS (TTM) is S$11.24. In 2024 the company made an earnings per share (EPS) of S$17.63 an increase over its 2023 EPS that were of S-$6.54.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$11.52-34.64%
2024S$17.63-369.77%
2023S-$6.54-60.46%
2022S-$16.5363.33%
2021S-$10.12-40.37%
2020S-$16.97183.47%
2019S-$5.99123.09%
2018S-$2.6854.93%
2017S-$1.7314.07%
2016S-$1.5213.05%
2015S-$1.34-36.34%
2014S-$2.11209.04%
2013S-$0.68-33.99%
2012S-$1.03185.59%
2011S-$0.36